,995
 lung cancer,12
 Lung cancer,11
 NSCLC,5
 Non-small-cell lung cancer,5
 Non-small cell lung cancer,5
 Nivolumab,4
 apoptosis,4
 non-small cell lung cancer,3
brain metastases,3
Cancer,3
 Inflammation,3
 smoking,3
Breast cancer,3
 non-small-cell lung cancer,2
 lung,2
 mortality,2
 radiotherapy,2
ALK,2
cancer,2
 Meta-analysis,2
 Prognosis,2
 Pembrolizumab,2
 screening,2
EGFR,2
 stereotactic radiosurgery,2
 Survival,2
Lung cancer,2
 cancer,2
 TNM,2
 Non-small-cell lung carcinoma,2
 chemotherapy,2
 stress,2
 Homozygous deletion of CDKN2A ,1
 malignant pleural effusion,1
 Differential diagnosis,1
 lncRNA,1
 cfDNA,1
 intraluminal polypoid mass,1
 Single molecule sensing,1
 cutaneous metastasis,1
 Overall survival,1
 Medicaid expansion,1
 Recurrence predictive model,1
 Cohort,1
 Ceritinib,1
 hierarchical linear modeling,1
bronchoscopy,1
 paclitaxel-resistant human lung adenocarcinoma cells ,1
 ovarian neoplasms,1
Drug-polymer conjugates,1
intensity-modulated radiotherapy,1
adenosine deaminase,1
 nausea,1
 nicotine,1
 Coal,1
Asia,1
 Plasminogen,1
 Metastasis,1
Postoperative management,1
 pulmonary mass,1
 SBRT,1
Carcinoma,1
 TILs,1
 pulmonary function,1
 Poly,1
 Nodules,1
 SABR,1
DDB2,1
Matched-pair analysis,1
 Radiotherapy,1
 Palliative care,1
 Meta- analysis,1
 and practice,1
 Positron Emission Tomography Computed Tomography,1
 sepsis,1
 Malignant nodules,1
 Immune checkpoint inhibitor,1
Bronchoalveolar lavage fluid,1
 Pleural effusion,1
Invitro cancer diagnosis,1
A549/TAX,1
 honokiol,1
 stem cells,1
 lung toxicity,1
Cancer-related fatigue,1
human microvascular endothelial cells,1
malignant pleural effusion,1
Video-assisted thoracic surgery ,1
 HGF,1
 exercise pulse oximetry,1
 gut brain axis,1
Cellular mechanism,1
BRCA1,1
 pulmonary complication,1
 Childhood,1
 methylation,1
HCV,1
 Mesothelioma,1
 cell cycle,1
 Multi-resolution patch-based convolutional neural network,1
C-reactive protein,1
CT imaging,1
MEK/ERK,1
 quality of life,1
 reactive oxygen species modulator 1,1
 recurrence,1
Early detection,1
 Segmentectomy,1
 Pathological type,1
 mosaic attenuation,1
Nausea,1
 long non-coding RNA MALAT1,1
 Heterogeneity,1
 Pulmonary lobectomy,1
PD-L1,1
 osimertinib,1
 AhR,1
Diagnostic marker,1
 infertility,1
 Staging,1
Mediastinal lymph node status,1
 histone,1
 herpesvirus,1
 tumor recurrence,1
CCL5,1
Notch3,1
 Radiology,1
 cirrhosis,1
 EUS,1
 PTMs,1
18F-FDG,1
 microbiome,1
 tobacco,1
Exhaled breath,1
Bilateral deep venous thrombosis,1
health communication,1
BLACAT1,1
HIV,1
 Prognostic factors,1
 lung nodule,1
 Drug therapy,1
 Metallic quantum probe,1
 Beta-blockers,1
 pseudoepitheliomatous hyperplasia,1
TFEB,1
 oncogene,1
 SVCS,1
 bronchiogenic carcinoma,1
 non-small cell lung cancer ,1
 trapped lung,1
 prognosis,1
conventional cytology,1
 PRMTs,1
 Superior vena cava syndrome,1
 Subtyping,1
 cost,1
 brain metastases,1
 morphine,1
Autoantibody,1
 Immunotherapy,1
 Urine,1
Pneumocystis jiroveci pneumonia,1
 Health care costs,1
 wheeze,1
 end-stage,1
 Thoracic surgery,1
 Wilson disease,1
 Impact assessment,1
 Incidence,1
 age,1
 preputial cystadenoma,1
 medically inoperable,1
 Micropapillary,1
 Non Small Cell Lung,1
 Obstacles and alternative approaches,1
 Reactive mesothelial proliferation,1
 cutaneous metastases,1
 SOD2,1
Epidural analgesia,1
 MET,1
FDG,1
 cisplatin,1
 Nodule guidelines,1
 senescence,1
 Clinical behaviour,1
 Prognostic factor,1
 tubular and branching opacities,1
Early stage,1
 hypertrophic lichen planus,1
 miRNA,1
 receptor tyrosine kinase,1
 Oncology,1
NSCLC,1
RSV,1
 Wheeze,1
chest computed tomography ,1
 Leptomeningeal carcinomatosis,1
 6-min walk test,1
Arginine methylation,1
 subcutaneous,1
 comorbidities,1
 epidermal growth factor receptor ,1
Epithelioid,1
 qualitative research,1
 Clinical practice guideline,1
 Rearrangement,1
 latent profile analysis,1
 navigational bronchoscopy,1
Adaptive radiotherapy,1
